APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enzyme-Linked Immunosorbent Assay (ELISA)

ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.

Selected research

Industry Growth & Trends

Global Enzyme-Linked Immunosorbent Assay (ELISA) Industry Growth and Trends Forecast to 2032

20 December 2025113 pages

Choose your research edition.

Industry ResearchEnzyme-Linked Immunosorbent Assay (ELISA) Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Enzyme-Linked Immunosorbent Assay (ELISA) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.

According to APO Research, the global Enzyme-Linked Immunosorbent Assay (ELISA) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Enzyme-Linked Immunosorbent Assay (ELISA) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Enzyme-Linked Immunosorbent Assay (ELISA) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Enzyme-Linked Immunosorbent Assay (ELISA) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Enzyme-Linked Immunosorbent Assay (ELISA).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Enzyme-Linked Immunosorbent Assay (ELISA) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Enzyme-Linked Immunosorbent Assay (ELISA) Market by Company

R&D Systems

Thermo Fisher Scientific

Ortho Clinical Diagnostics

BD Biosciences

ZEUS Scientific

Bio-Rad Laboratories

ALPCO

Enzo Life Sciences

BioMérieux

EMD Millipore

BioLegend

LOEWE Biochemica

Mercodia

Cusabio

Shanghai Kehua Bio-engineering

Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Type

Sandwich ELISA

Indirect ELISA

Competitive ELISA

Others

Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Application

Immunology

Inflammation

Infectious Diseases

Cancer

Protein Quantitation

Others

Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzyme-Linked Immunosorbent Assay (ELISA) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enzyme-Linked Immunosorbent Assay (ELISA) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzyme-Linked Immunosorbent Assay (ELISA).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Enzyme-Linked Immunosorbent Assay (ELISA) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Region (2021-2026) Table 4. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Region (2027-2032) Table 6. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Share by Type (2021-2026) Table 9. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Share Forecasted by Type (2027-2032) Table 11. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Share by Application (2021-2026) Table 24. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Share Forecasted by Application (2027-2032) Table 26. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Enzyme-Linked Immunosorbent Assay (ELISA) Industry Trends Table 37. Enzyme-Linked Immunosorbent Assay (ELISA) Industry Drivers Table 38. Enzyme-Linked Immunosorbent Assay (ELISA) Industry Opportunities and Challenges Table 39. Enzyme-Linked Immunosorbent Assay (ELISA) Industry Restraints Table 40. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Company (2021-2026) Table 42. Global Enzyme-Linked Immunosorbent Assay (ELISA) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Enzyme-Linked Immunosorbent Assay (ELISA) Key Company Headquarters & Area Served Table 44. Global Enzyme-Linked Immunosorbent Assay (ELISA) Company, Product Type & Application Table 45. Global Enzyme-Linked Immunosorbent Assay (ELISA) Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Enzyme-Linked Immunosorbent Assay (ELISA) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. R&D Systems Company Information Table 49. R&D Systems Business Overview Table 50. R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 52. R&D Systems Recent Development Table 53. Thermo Fisher Scientific Company Information Table 54. Thermo Fisher Scientific Business Overview Table 55. Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 57. Thermo Fisher Scientific Recent Development Table 58. Ortho Clinical Diagnostics Company Information Table 59. Ortho Clinical Diagnostics Business Overview Table 60. Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 62. Ortho Clinical Diagnostics Recent Development Table 63. BD Biosciences Company Information Table 64. BD Biosciences Business Overview Table 65. BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 67. BD Biosciences Recent Development Table 68. ZEUS Scientific Company Information Table 69. ZEUS Scientific Business Overview Table 70. ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 72. ZEUS Scientific Recent Development Table 73. Bio-Rad Laboratories Company Information Table 74. Bio-Rad Laboratories Business Overview Table 75. Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 77. Bio-Rad Laboratories Recent Development Table 78. ALPCO Company Information Table 79. ALPCO Business Overview Table 80. ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 82. ALPCO Recent Development Table 83. Enzo Life Sciences Company Information Table 84. Enzo Life Sciences Business Overview Table 85. Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 87. Enzo Life Sciences Recent Development Table 88. BioMérieux Company Information Table 89. BioMérieux Business Overview Table 90. BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 92. BioMérieux Recent Development Table 93. EMD Millipore Company Information Table 94. EMD Millipore Business Overview Table 95. EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 97. EMD Millipore Recent Development Table 98. BioLegend Company Information Table 99. BioLegend Business Overview Table 100. BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 102. BioLegend Recent Development Table 103. LOEWE Biochemica Company Information Table 104. LOEWE Biochemica Business Overview Table 105. LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 107. LOEWE Biochemica Recent Development Table 108. Mercodia Company Information Table 109. Mercodia Business Overview Table 110. Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 112. Mercodia Recent Development Table 113. Cusabio Company Information Table 114. Cusabio Business Overview Table 115. Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 117. Cusabio Recent Development Table 118. Shanghai Kehua Bio-engineering Company Information Table 119. Shanghai Kehua Bio-engineering Business Overview Table 120. Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio Table 122. Shanghai Kehua Bio-engineering Recent Development Table 123. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country (2021-2026) Table 126. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Share Forecast by Country (2027-2032) Table 128. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country (2021-2026) Table 131. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country (2021-2026) Table 136. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Share Forecast by Country (2027-2032) Table 138. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country (2021-2026) Table 141. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country (2021-2026) Table 146. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Enzyme-Linked Immunosorbent Assay (ELISA) Product Image Figure 3. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032) & (US$ Million) Figure 5. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Region: 2025 VS 2032 Figure 6. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Region (2021-2032) Figure 7. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Sandwich ELISA Image Figure 13. Global Sandwich ELISA Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Indirect ELISA Image Figure 15. Global Indirect ELISA Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Competitive ELISA Image Figure 17. Global Competitive ELISA Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Type 2025 VS 2032 Figure 22. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Share by Type (2021-2032) Figure 23. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Share by Type (2021-2032) Figure 25. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Share by Type (2021-2032) Figure 27. Immunology Image Figure 28. Global Immunology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Inflammation Image Figure 30. Global Inflammation Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Infectious Diseases Image Figure 32. Global Infectious Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Cancer Image Figure 34. Global Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Protein Quantitation Image Figure 36. Global Protein Quantitation Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Others Image Figure 38. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Application 2025 VS 2032 Figure 41. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Share by Application (2021-2032) Figure 42. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Share by Application (2021-2032) Figure 44. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 Enzyme-Linked Immunosorbent Assay (ELISA) Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country (2021-2032) Figure 51. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country (2021-2032) Figure 54. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country (2021-2032) Figure 57. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country (2021-2032) Figure 60. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Sandwich ELISA
  • Indirect ELISA
  • Competitive ELISA
  • Others
Applications
  • Immunology
  • Inflammation
  • Infectious Diseases
  • Cancer
  • Protein Quantitation
  • Others
Companies covered
  • R&D Systems
  • Thermo Fisher Scientific
  • Ortho Clinical Diagnostics
  • BD Biosciences
  • ZEUS Scientific
  • Bio-Rad Laboratories
  • ALPCO
  • Enzo Life Sciences
  • BioMérieux
  • EMD Millipore
  • BioLegend
  • LOEWE Biochemica
  • Mercodia
  • Cusabio
  • Shanghai Kehua Bio-engineering

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region (2021-2032)
  5. 1.4.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region (2021-2026)
  6. 1.4.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region (2027-2032)
  7. 1.5 Key Regions Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2021-2032)
  8. 1.5.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (2021-2032)
2 Enzyme-Linked Immunosorbent Assay (ELISA) Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Sandwich ELISA
  3. 2.1.2 Indirect ELISA
  4. 2.1.3 Competitive ELISA
  5. 2.1.4 Others
  6. 2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Type
  7. 2.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Regions
  11. 2.3.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Type (2021-2026)
3 Enzyme-Linked Immunosorbent Assay (ELISA) Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Immunology
  3. 3.1.2 Inflammation
  4. 3.1.3 Infectious Diseases
  5. 3.1.4 Cancer
  6. 3.1.5 Protein Quantitation
  7. 3.1.6 Others
  8. 3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Application
  9. 3.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Overview by Application (2021-2032)
  10. 3.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Historic Market Size Review by Application (2021-2026)
  11. 3.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Forecasted by Application (2027-2032)
  12. 3.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Regions
  13. 3.3.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Application (2021-2026)
  14. 3.3.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Application (2021-2026)
  15. 3.3.3 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Application (2021-2026)
  16. 3.3.4 South America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Application (2021-2026)
  17. 3.3.5 Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Trends
  2. 4.2 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Drivers
  3. 4.3 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Opportunities and Challenges
  4. 4.4 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Enzyme-Linked Immunosorbent Assay (ELISA) Revenue (2021-2026)
  2. 5.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Key Company Headquarters & Area Served
  4. 5.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Company, Product Type & Application
  5. 5.5 Global Enzyme-Linked Immunosorbent Assay (ELISA) Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Enzyme-Linked Immunosorbent Assay (ELISA) Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Enzyme-Linked Immunosorbent Assay (ELISA) Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 R&D Systems
  2. 6.1.1 R&D Systems Company Information
  3. 6.1.2 R&D Systems Business Overview
  4. 6.1.3 R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  6. 6.1.5 R&D Systems Recent Developments
  7. 6.2 Thermo Fisher Scientific
  8. 6.2.1 Thermo Fisher Scientific Company Information
  9. 6.2.2 Thermo Fisher Scientific Business Overview
  10. 6.2.3 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  12. 6.2.5 Thermo Fisher Scientific Recent Developments
  13. 6.3 Ortho Clinical Diagnostics
  14. 6.3.1 Ortho Clinical Diagnostics Company Information
  15. 6.3.2 Ortho Clinical Diagnostics Business Overview
  16. 6.3.3 Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  18. 6.3.5 Ortho Clinical Diagnostics Recent Developments
  19. 6.4 BD Biosciences
  20. 6.4.1 BD Biosciences Company Information
  21. 6.4.2 BD Biosciences Business Overview
  22. 6.4.3 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  24. 6.4.5 BD Biosciences Recent Developments
  25. 6.5 ZEUS Scientific
  26. 6.5.1 ZEUS Scientific Company Information
  27. 6.5.2 ZEUS Scientific Business Overview
  28. 6.5.3 ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  30. 6.5.5 ZEUS Scientific Recent Developments
  31. 6.6 Bio-Rad Laboratories
  32. 6.6.1 Bio-Rad Laboratories Company Information
  33. 6.6.2 Bio-Rad Laboratories Business Overview
  34. 6.6.3 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  36. 6.6.5 Bio-Rad Laboratories Recent Developments
  37. 6.7 ALPCO
  38. 6.7.1 ALPCO Company Information
  39. 6.7.2 ALPCO Business Overview
  40. 6.7.3 ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  42. 6.7.5 ALPCO Recent Developments
  43. 6.8 Enzo Life Sciences
  44. 6.8.1 Enzo Life Sciences Company Information
  45. 6.8.2 Enzo Life Sciences Business Overview
  46. 6.8.3 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  48. 6.8.5 Enzo Life Sciences Recent Developments
  49. 6.9 BioMérieux
  50. 6.9.1 BioMérieux Company Information
  51. 6.9.2 BioMérieux Business Overview
  52. 6.9.3 BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  54. 6.9.5 BioMérieux Recent Developments
  55. 6.10 EMD Millipore
  56. 6.10.1 EMD Millipore Company Information
  57. 6.10.2 EMD Millipore Business Overview
  58. 6.10.3 EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  60. 6.10.5 EMD Millipore Recent Developments
  61. 6.11 BioLegend
  62. 6.11.1 BioLegend Company Information
  63. 6.11.2 BioLegend Business Overview
  64. 6.11.3 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  66. 6.11.5 BioLegend Recent Developments
  67. 6.12 LOEWE Biochemica
  68. 6.12.1 LOEWE Biochemica Company Information
  69. 6.12.2 LOEWE Biochemica Business Overview
  70. 6.12.3 LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  72. 6.12.5 LOEWE Biochemica Recent Developments
  73. 6.13 Mercodia
  74. 6.13.1 Mercodia Company Information
  75. 6.13.2 Mercodia Business Overview
  76. 6.13.3 Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  78. 6.13.5 Mercodia Recent Developments
  79. 6.14 Cusabio
  80. 6.14.1 Cusabio Company Information
  81. 6.14.2 Cusabio Business Overview
  82. 6.14.3 Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  84. 6.14.5 Cusabio Recent Developments
  85. 6.15 Shanghai Kehua Bio-engineering
  86. 6.15.1 Shanghai Kehua Bio-engineering Company Information
  87. 6.15.2 Shanghai Kehua Bio-engineering Business Overview
  88. 6.15.3 Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
  90. 6.15.5 Shanghai Kehua Bio-engineering Recent Developments
7 North America
  1. 7.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026)
  3. 7.3 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026)
  3. 8.3 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026)
  3. 10.3 South America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst